Yes, it is possible to reverse type 2 diabetes, and there is now strong clinical evidence showing how. The medical community uses the term “remission” rather than “cure,” defined as maintaining an HbA1c below 6.5% for at least three months without any diabetes medication. Remission is most achievable for people diagnosed within the last six years who have not yet started insulin, but it has also been documented in people with longer disease duration.
What Happens Inside Your Body
Type 2 diabetes develops when fat accumulates in two places it shouldn’t: the liver and the pancreas. Excess fat in the liver causes it to pump out too much glucose, raising your fasting blood sugar. At the same time, that liver fat gets exported as fatty particles to the pancreas, where toxic byproducts interfere with the insulin-producing beta cells. Those cells don’t die immediately. They become sluggish and dysfunctional under the chronic stress of fat exposure.
This is the key insight that makes reversal possible. The damage is functional, not permanent, at least in the earlier stages. When you create a significant calorie deficit and lose weight, fat drains from the liver first (often within days), then gradually from the pancreas. As pancreatic fat drops, beta cells begin recovering their ability to produce insulin normally. Research from the DiRECT trial found that the maximum rate of insulin secretion after weight loss became comparable to people without diabetes by 12 months, and that recovery held steady at two years. The early, rapid response to insulin (called first-phase insulin response) also improved significantly, though it remained slightly below non-diabetic levels even at 24 months. So beta cells can recover substantially, but not always completely.
How Much Weight Loss Is Needed
The relationship between weight loss and remission is dose-dependent: the more weight you lose, the better your odds. In the DiRECT trial, which studied people diagnosed within six years who were not on insulin, 46% of participants in the intervention group achieved remission at 12 months. Among those who maintained over 10 kg (about 22 pounds) of weight loss at two years, 81% were in remission. That’s a striking number, and it underscores that the amount of weight lost matters more than the specific method used to lose it.
The threshold isn’t the same for everyone. Some people enter remission after losing 10 to 15 kg, while others with longer disease duration or more severe beta cell decline may need greater loss or may not achieve remission at all. People diagnosed more recently have a clear advantage because their beta cells have spent less time under metabolic stress and retain more capacity to bounce back.
Very Low-Calorie Diet Programs
The most studied approach for diabetes remission uses a structured very low-calorie diet, typically 600 to 850 calories per day from liquid meal replacements, lasting 12 to 20 weeks. These programs also allow small amounts of non-starchy vegetables. After the intensive phase, solid food is gradually reintroduced over several weeks, with calories stepped up in stages toward a sustainable maintenance level.
This approach produces rapid, substantial weight loss of 20 to 30% of body weight in some cases. The speed matters because it creates the sharp negative energy balance needed to flush fat out of the liver and pancreas quickly. The DiRECT trial used a 16 to 20 week total diet replacement at 825 to 853 calories per day, followed by structured food reintroduction over two to eight weeks. Shorter protocols of eight to ten weeks at around 600 calories daily have also shown success in smaller studies.
These programs are medically supervised for good reason. Diabetes medications, especially insulin and drugs that stimulate insulin release, typically need to be adjusted or stopped before starting, because the combination of very low calorie intake and blood sugar-lowering medication can cause dangerous drops in blood sugar.
Low-Carbohydrate Diets
Low-carbohydrate and ketogenic diets take a different route to the same destination. Rather than restricting total calories dramatically, they cut carbohydrates to reduce the blood sugar spikes that drive insulin demand. The evidence here is encouraging but shows a familiar pattern: strong initial results that fade over time without ongoing support.
A systematic review of long-term low-carb studies found that HbA1c levels dropped significantly in the first year, and 87% of participants were able to stop their glucose-lowering medications. One practice-based study tracked patients over eight years and showed a sustained HbA1c reduction from diabetic levels down to normal range. But in studies with five-year follow-up, average HbA1c crept back up to slightly above baseline, and only 40% of participants remained medication-free. Antihypertensive medication use followed a similar arc, improving at one year then partially reverting by year five.
These numbers don’t mean the diet failed. They reflect how difficult it is to maintain any major dietary change over years. The people who stuck with it generally kept their improvements.
Bariatric Surgery
Weight loss surgery produces the highest remission rates, particularly for people with more severe obesity or longer disease duration who haven’t responded to lifestyle changes alone. A large meta-analysis of over 135,000 patients found remission rates of about 57% for gastric banding, 80% for gastric bypass, and 95% for a more extensive procedure called biliopancreatic diversion. When researchers applied stricter remission criteria in a UK study, the rates were lower but still meaningful: 41% after gastric bypass, 26% after sleeve gastrectomy, and 7% after gastric banding.
The STAMPEDE trial, which randomized 150 people with poorly controlled diabetes to either intensive medical management alone, gastric bypass, or sleeve gastrectomy, found that 42% of the bypass group and 37% of the sleeve group reached the target HbA1c, compared to just 12% with medication alone.
Surgery works partly through the same mechanism as diet (rapid fat loss from the liver and pancreas) but also triggers hormonal changes in the gut that independently improve blood sugar regulation. A five-year study of sleeve gastrectomy found that 46% of patients maintained diabetes remission at the five-year mark. About 9% of all patients who initially achieved remission relapsed within five years, highlighting that even after surgery, remission is not always permanent.
Why Timing Matters
The single strongest predictor of whether remission is achievable is how long you’ve had diabetes. Beta cells can recover from fat-related stress, but over years of chronic exposure, some of those cells are lost permanently. The longer the disease has been present, the fewer functional beta cells remain to recover, and the harder it becomes to restore normal insulin production.
The DiRECT trial enrolled only people diagnosed within the previous six years who were not yet on insulin. Even within that relatively early-stage group, 46% achieved remission at 12 months. People diagnosed more recently within that window tended to do better than those closer to the six-year mark. For someone diagnosed ten or fifteen years ago, remission becomes less likely through lifestyle changes alone, though bariatric surgery can still produce results in some cases.
This doesn’t mean that weight loss is pointless for people with longer-standing diabetes. Even without achieving full remission, significant weight loss improves blood sugar control, reduces medication requirements, and lowers the risk of complications. The benefits exist on a spectrum, not just at the threshold of remission.
Staying in Remission
Achieving remission is one challenge. Maintaining it is another. Type 2 diabetes is driven by a susceptibility to fat accumulation in the liver and pancreas, and that susceptibility doesn’t go away. If weight is regained, fat re-accumulates in those organs, beta cells come under stress again, and blood sugar rises. Remission, in most cases, depends on keeping the weight off.
The five-year data on this is sobering but realistic. After sleeve gastrectomy, 54% of patients who initially achieved remission no longer met remission criteria at five years. In the low-carb diet literature, a majority of participants saw their blood sugar improvements erode by year five. The DiRECT trial found that remission rates were tightly linked to sustained weight loss at every follow-up point.
Structured maintenance support, whether through ongoing dietary counseling, regular follow-up, or behavioral programs, appears to make a significant difference. The people who maintained weight loss maintained remission. The biology is clear: if you can keep the fat out of your liver and pancreas, your beta cells can keep doing their job.